The Histone Deacetylase Inhibitor, Vorinostat, Reduces...

Molecular Cancer Therapeutics 2010 / 12 Vol. 9; Iss. 12

The Histone Deacetylase Inhibitor, Vorinostat, Reduces Tumor Growth at the Metastatic Bone Site and Associated Osteolysis, but Promotes Normal Bone Loss

Pratap, J., Akech, J., Wixted, J. J., Szabo, G., Hussain, S., McGee-Lawrence, M. E., Li, X., Bedard, K., Dhillon, R. J., van Wijnen, A. J., Stein, J. L., Stein, G. S., Westendorf, J. J., Lian, J. B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-10-0572
Date:
December, 2010
File:
PDF, 2.15 MB
english, 2010
Conversion to is in progress
Conversion to is failed